The TREOCAPA trial was a multicenter, phase III study involving 14 European countries. The study investigated the preventive use of paracetamol, in preterm infants (23–26 weeks of gestation), evaluating its impact on the closure of patent ductus arteriosus as well as on common complications associated with preterm birth. conect4children worked in close collaboration with the sponsor INSERM, ECRIN, and GFCNI, to support the study’s execution. In Portugal, the three participating sites were also supported by STAND4Kids...Continue Reading

This month’s newsletter highlights our activities from November 2025 to February 2026. In this edition, we share the events where STAND4Kids was present and highlight our role in Portugal Clinical Studies as a thematic network and service provider. For more information about Portugal Clinical Studies, visit: https://portugalclinicalstudies.com/ Download [HERE].Continue Reading

Hospital Pediátrico de Coimbra (ULS de Coimbra – Principal Investigator Dr. Catarina Neves) has enrolled the first national participant in the EMPA-KIDNEY Kids study. The EMPA-KIDNEY Kids study aims to assess the pharmacokinetics, safety, and efficacy of empagliflozin tablets in children and adolescents aged 2 to 17 years with chronic kidney disease. Study details are...Continue Reading

Our Highlights this month are dedicated to our activities from July to October. This edition showcases our main activities aimed at promoting high quality paediatric clinical trials. Download [HERE].Continue Reading

Ricardo Fernandes, STAND4Kids Lead, has been elected the new Chair of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Coordinating Group. Congratulations!Continue Reading

Collaboration is everything! A heartfelt thank you to Boehringer Ingelheim for inviting us to join and support the European Investigators’ Meeting. STAND4Kids is proud to be part of the launch of this exciting paediatric chronic kidney disease (CKD) study. With our team engaged, we are committed to helping Boehringer Ingelheim move swiftly through study enrollment...Continue Reading

Our Highlights this month are dedicated to our activities from March to June. This edition showcases the main activities of the STAND4Kids network during the conclusion of the conect4children (c4c) project, and looks ahead to the future of the network and the conect4children Stichting. Together, we will continue working to promote high-quality paediatric clinical trials....Continue Reading

We are pleased to announce the release of a new video that showcases the mission and vision of STAND4Kids. Since 2018, STAND4Kids has been working to build and strengthen a national network dedicated to paediatric clinical trials in Portugal. This video highlights our commitment to: Supporting the implementation and feasibility of paediatric clinical trials Promoting...Continue Reading

We’re thrilled to share the new video and flyer from YPAG Lisboa, a dynamic group of young people helping to shape the future of paediatric research. YPAG Lisboa brings together children and young people who actively contribute as partners in clinical research. They advise researchers and their teams on study design, communication, and engagement strategies,...Continue Reading

On International Clinical Trials Day, STAND4Kids attended the event Clinical Trials: Inclusion and Patient Involvement in Clinical Research, organised by APIFARMA and EUPATI Portugal. Ricardo Fernandes joined the roundtable “Patient Involvement in Clinical Research: The Road Ahead”, contributing to a discussion on how to strengthen patient engagement, including the voices of children and families, in...Continue Reading